Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Associated Factors of Impaired Fasting Glucose in Some Korean Rural Adults

농촌지역 주민의 공복혈당장애와 관련요인

  • Yun, Hye-Eun (Department of Health Sciences, Graduate School of Chosun University) ;
  • Han, Mi-Ah (National Cancer Control Research Institute, National CancerCenter) ;
  • Kim, Ki-Soon (Department of Preventive Medicine, Chosun University Medical School) ;
  • Park, Jong (Department of Preventive Medicine, Chosun University Medical School) ;
  • Kang, Myeng-Guen (Department of Preventive Medicine, Chosun University Medical School) ;
  • Ryu, So-Yeon (Department of Preventive Medicine, Chosun University Medical School)
  • 윤혜은 (조선대학교 대학원 보건학과) ;
  • 한미아 (국립암센타 국가암관리사업단) ;
  • 강명근 (조선대학교 의과대학 예방의학교실) ;
  • 박종 (조선대학교 의과대학 예방의학교실) ;
  • 김기순 (조선대학교 의과대학 예방의학교실) ;
  • 류소연 (조선대학교 의과대학 예방의학교실)
  • Received : 2010.02.17
  • Accepted : 2010.05.12
  • Published : 2010.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study was performed to investigate the prevalence of impaired fasting glucose (IFG) and its related characteristics among healthy adults in some Korean rural areas. Methods: We conducted a cross-sectional study using the data from 1352 adults who were over the age 40 and under the age 70 and who were free of diabetes mellitus (DM), cardiovascular diseases and other diseases and who participated in a survey conducted as part of the Korean Rural Genomic Cohort Study. IFG was defined as a serum fasting glucose level between 100 and 125 mg/dL. Results: The prevalence of IFG was 20.4% in men, 15.5% in women and 12.7% overall. Multivariate logistic regression analysis demonstrated that the independent risk factors for IFG were male gender, having a family history of DM, the quartiles of gamma glutamyltransferase and high sensitive C-reactive protein and the waist circumference. The homeostatis model assessment for insulin resistance was very strongly associated with IFG. The prevalence of metabolic syndrome (MS) and MS components was higher in the subjects with IFG then in those with normal fasting glucose (NFG). Conclusions: The result of study could supply evidence to find the high risk population and to determine a strategy for treating IFG. Further research is needed to explain the causal relationship and mechanisms of IFG.

Keywords

References

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5): 1047-1053. https://doi.org/10.2337/diacare.27.5.1047
  2. Kim JS, Kim YJ, Park SI, Hong YP. Mean fasting blood glucose level and an estimated prevalence of diabetes mellitus among a representative adult Korean population. Korean J Prev Med 1993; 26(3): 311-320. (Korean)
  3. Ministry of Health & Welfare; Korea Centers for Disease Control and Prevention. 2007 National Health Statistics: The fourth Korean National Health and Nutrition Examination Survey, 1st Year Results. Seoul: Korea Centers for Disease Control and Prevention; 2007. (Korean)
  4. Unwin N, Shaw J, Zimmet P, Alberti KGM. Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med 2002; 19(9): 708-723. https://doi.org/10.1046/j.1464-5491.2002.00835.x
  5. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20(7): 1183-1197. https://doi.org/10.2337/diacare.20.7.1183
  6. Del Prato S, Marchetti P, Bonadonna RC. Phasic insulin release and metabolic regulation in type 2 diabetes. Diabetes 2002; 51(Suppl 1): S109-S116. https://doi.org/10.2337/diabetes.51.2007.S109
  7. Lim SC, Tai ES, Tan BY, Chew SK, Tan CE. Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report. Diabetes Care 2000; 23(3): 278-282. https://doi.org/10.2337/diacare.23.3.278
  8. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolearnce and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161(3): 397-405. https://doi.org/10.1001/archinte.161.3.397
  9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27(Suppl 1): S5-S10. https://doi.org/10.2337/diacare.27.2007.S5
  10. Bjornholt JV, Erikssen G, Aaser E, Sandivik L, Nitter- Hauge S, Jervell J, et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 1999; 22(1): 45-49. https://doi.org/10.2337/diacare.22.1.45
  11. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344(18): 1343-1350. https://doi.org/10.1056/NEJM200105033441801
  12. Jiamjarasrangsi W, Sangwatanaroj S, Lohsoonthorn V, Lermaharit S. Increased alanine aminotransferase level and future risk of type 2 diabetes and impaired fasting glucose among the employees in a university hospital in Thailand. Diabetes Metab 2008; 34(3): 283-289. https://doi.org/10.1016/j.diabet.2008.01.009
  13. Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med 2003; 254(3): 287-295. https://doi.org/10.1046/j.1365-2796.2003.01198.x
  14. Sakai Y, Yamaji T, Tabata S, Ogawa S, Yamaguchi K, Mineshita M, et al. Relation of alcohol use and smoking to glucose tolerance status in Japanese men. Diabetes Res Clin Pract 2006; 73(1): 83-88. https://doi.org/10.1016/j.diabres.2005.12.010
  15. Rafalson L, Donahue RP, Dmochowski J, Rejman K, Dorn J, Trevisan M. Cigarette smoking is associated with conversion from normoglycemia to impaired fasting glucose: the Western New York Health Study. Ann Epidemiol 2009; 19(6): 365-371. https://doi.org/10.1016/j.annepidem.2009.01.013
  16. Kriska AM, LaPorte RE, Pettitt DJ, Charles MA, Nelson RG, Kuller LH, et al. The association of physical activity with obesity, fat distribution and glucose intolearnce in Pima Indians. Diabetologia 1993; 36(9): 863-869. https://doi.org/10.1007/BF00400363
  17. Kim JH, Han MH, Park CJ, Park IG, Shin JH, Kim SY, et al. Evaluation of fasting plasma glucose as a screening for diabetes mellitus in middle-aged adults of Naju county. Korean Diabetes J 2008; 32(4): 328-337. (Korean) https://doi.org/10.4093/kdj.2008.32.4.328
  18. Ryu S, Shin H, Chang Y, Sung KC, Song J, Lee SJ. Should the lower limit of impaired fasting glucose be reduced from 110 mg/dL in Korea? Metabolism 2006; 55(4): 489-493. https://doi.org/10.1016/j.metabol.2005.10.010
  19. Ryu SH, Beck SH, Chang YS, Kim DI, Suh BS, Kim WS, et al. Abdominal obesity in relation to the incidence of type 2 diabetes mellitus and impaired fasting glucose among some Korean adults: a retrospective cohort study. J Prev Med Public Health 2004; 37(4): 359-365. (Korean)
  20. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007; 75(1): 72-80. https://doi.org/10.1016/j.diabres.2006.04.013
  21. Matthews DR, Hosker JP, Rudenski AS, Neylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28(7): 412-419. https://doi.org/10.1007/BF00280883
  22. Korea Centers for Disease Control and Prevention. Indepth Study Report of the Third Korean National Health and Nutrition Examination Survey: Health Examination Parts. Seoul: Korea Centers for Disease Control and Prevention; 2007. (Korean)
  23. Song KH, Nam-Goomg IS, Han SM, Kim MS, Lee EJ, Lee YS, et al. Change in prevalence and 6-year incidence of diabetes and impaired fasting glucose in Korean subjects living in a rural area. Diabetes Res Clin Pract 2007; 78(3): 378-384. https://doi.org/10.1016/j.diabres.2007.04.011
  24. Kim CS, Jeong EK, Park JA, Cho MH, Nam JS, Kim HJ, et al. Prevalence of diabetes mellitus(fasting plasma glucose by the ADA criteria) and impaired fasting glucose according to anthropometric characteristics and dietary habits - 1998 National Health and Nutrition Survey -. Korean Diabetes J 2005; 29(2): 151-166. (Korean)
  25. Chen LK, Lin MH, Chen ZJ, Hwang SJ, Tsai ST, Chiou ST. Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese. Diabetes Res Clinic Pract 2006; 71(2): 170-176.
  26. Hung WW, Chang CJ, Lee YJ, Hsin SC, Lin KD, Hsieh MC, et al. Metabolic risk factors in southern Taiwanese with impaired fasting glucose of 100 to 109 mg/dL. Metabolism 2007; 56(4): 528-532. https://doi.org/10.1016/j.metabol.2006.11.013
  27. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance: A potential link with the insulin resistance syndrome. J Intern Med 1993; 233(4): 327-332. https://doi.org/10.1111/j.1365-2796.1993.tb00680.x
  28. Park CH, Ga H, Lim JH, Gwak SM, Kim HC, Choi JH. The effect of smoking status upon occurrence of impaired fasting glucose or type 2 diabetes in Korean men. J Prev Med Public Health 2008; 41(4): 249-254. (Korean) https://doi.org/10.3961/jpmph.2008.41.4.249
  29. Um HD, Lee DC, Lee SY, Kim YS. A prospective cohort study of exercise and the incidence of type 2 diabetes in impaired fasting glucose group. J Prev Med Public Health 2008; 41(1): 45-50. (Korean) https://doi.org/10.3961/jpmph.2008.41.1.45
  30. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286(3): 327-334. https://doi.org/10.1001/jama.286.3.327
  31. Howard BV, Best L, Comuzzie A, Ebbesson SO, Epstein SE, Fabsitz RR, et al. C-Reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: Insights from the Genetics of Coronary Artery Disease in Alaska Natives (GCADAN) study. Diabetes Care 2008; 31(12): 2312-2314. https://doi.org/10.2337/dc08-0815
  32. Kim YC, Lee EJ, Yoo TW, Hwang ST, Oh SY, CHun HB, et al. Comparison of insulin resistance and serum hsCRP levels according to the fasting blood glucose and blood pressure in nondiabetic and normotensive range. Korean J Med 2005; 68(2): 178-185. (Korean)
  33. Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med 2004; 37(7): 1018-1023. https://doi.org/10.1016/j.freeradbiomed.2004.06.032
  34. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol 2004; 61(1): 75-80. https://doi.org/10.1111/j.1365-2265.2004.02063.x
  35. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramacnandran A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care 2003; 26(12): 3226-3229. https://doi.org/10.2337/diacare.26.12.3226
  36. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002; 51(6): 1884-1888. https://doi.org/10.2337/diabetes.51.6.1884
  37. Kelly DE, Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000; 49(5): 677-683. https://doi.org/10.2337/diabetes.49.5.677
  38. Jellinger PS. Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone 2007; 8(Suppl 7): S30-S42. https://doi.org/10.1016/S1098-3597(07)80019-6
  39. Lee S, Kang ES, Lee KE, Jin H, Choi SH, Kim DJ, et al. Insulin resistance can predict the risk of metabolic syndrome. Korean J Med 2002; 63(1): 54-60. (Korean)

Cited by

  1. 당뇨병이 없는 성인의 비만 여부에 따른 공복혈당장애 관련 요인 vol.18, pp.6, 2010, https://doi.org/10.5762/kais.2017.18.6.180